News Archives - IIS Biodonostia

Biodonostia obtains the Stamp of Excellence in Human Resources Policies for Researchers awarded by the European Commission

The stamp accredits the Osakidetza Health Research Institute as a centre which manages its human resources policy in exemplary fashion, being a stimulating and favourable workplace The ‘Human Resources Strategy for Researchers’ (HRS4R) distinction awarded by the European Commission, publicly recognises research centres which develop Human ... + info

Biodonostia to co-lead an international project for studying the role of obesity in developing non-alcoholic fatty liver disease

Over the next 3 years, the Osakidetza Biodonostia Health Research Institute will co-lead a collaborative research project headed by the Faculty of Pharmacy, University of Lisbon, focussed on research into the part played by extracellular vesicles as non-invasive biomarkers of non-alcoholic fatty liver disease (or NAFLD), and on its development ... + info

The 4D-Healing project takes off at Biodonostia

On June 21st and 22nd, the Biodonostia HRI hosted the meeting to launch the European project “Data-Driven Drug Discovery for Wound Healing (4D-HEALING)”, coordinated by Dr. Marcos J. Araúzo-Bravo, leader of the Institute’s Computational Biology and Systems Biomedicine Group, in which Dr. Ander Izeta from the Tissue Engineering Group ... + info

Biodonostia contributes with its research to improving the identification and treatment of ALS

ALS is an enormously heterogeneous disease in regard to the progression rate of its symptoms and survival time, and there are no tools to predict these clinical variables. However, an early prognosis on development of the disease could enable neurologists to anticipate decisions which favour the patient’s quality of life and to more ... + info

“Stop The Brain Drain” grant from the Basque Country for a Biodonostia researcher

The IIS Biodonostia headquarters in San Sebastian today held the presentation of the “Stop Brain Drain” grant, an initiative launched by Roche Farma, with the aim of retaining research talent who is forced to leave the country due to the lack of resources to develop their projects. The recipient of this latest grant was Estefanía […]

A project led by scientists from Biodonostia identifies new genetic causes of Irritable Bowel Syndrome in women

An international research team led by Ikerbasque Professor Mauro D’Amato, Head of the Gastrointestinal Genetics Group of the Osakidetza Biodonostia Health Research Institute has identified new genetic variants linked to the risk of suffering from Irritable Bowel Syndrome (IBS) in women. The results, published in the scientific journal ... + info

Jesús Bañales from Biodonostia, the Easl Young Investigator Award 2018

The International Liver Congress organised by the European Association for the Study of the Liver (EASL) held its annual conference from 11 to 15 April last in Paris, which brought together scientific and medical experts from around the world to find out about and share the latest research on liver diseases. There was an emphasis […]

New keys for finding out more about the causes of Irritable Bowel Syndrome

An international research team led by Ikerbasque researcher Mauro D’Amato of the Osakidetza Biodonostia Health Research Institute has identified new causes of irritable bowel syndrome (IBS). It has found a specific correlation between genetic factors, carbohydrate consumption and microbiota and the risk of suffering from this disorder. ... + info

Biodonostia’s coordination of an INTER-CIBEREHD project to combat bladder cancer funded with a €300,000 grant from AECC

The Osakidetza Biodonostia Health Research Institute will be coordinating a collaborative research project with a duration of approximately three years focused on conducting research on a rare type of bladder cancer, cholangiocarcinoma (CCA), which claims the lives of 70,000 people worldwide each year. The heads of the four participating ... + info

Biodononostia granted Quality Management Systems Certification from AENOR for its Histology, Genomics and Molecular Diagnostics Platforms and renews its R & D Management Certificate

AENOR notified IIS Biodonostia on 24 January last of its obtainment of the Quality Mangement System Certification, in accordance with Standard ISO 9001:2015 on the Institute’s Histology, Genomics and Molecular Diagnostics Platforms. This was very exciting and satisfying news for the Institute, thanks to the support for the Platforms ... + info

BioNet Access